Oculis Holding AG (OCS)
30.30
-1.07
(-3.41%)
USD |
NASDAQ |
May 14, 10:16
Oculis Enterprise Value : 1.545B for May 13, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Novartis AG | 326.17B |
| Roche Holding AG | -- |
| Addex Therapeutics Ltd. | 6.439M |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -36.82M |
| Total Expenses (Quarterly) | 36.82M |
| EPS Diluted (Quarterly) | -0.625 |
| Earnings Yield | -7.06% |
| Normalized Earnings Yield | -6.653 |